Arch Therapeutics, Inc. Quarterly Inventory, Net in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Arch Therapeutics, Inc. quarterly Inventory, Net history and growth rate from Q3 2018 to Q2 2024.
  • Arch Therapeutics, Inc. Inventory, Net for the quarter ending June 30, 2024 was $1.32M, a 4.53% decline year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.32M -$62.7K -4.53% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $1.33M -$72.8K -5.19% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.34M -$79K -5.58% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $1.36M -$50.3K -3.56% Sep 30, 2023 10-Q 2024-08-19
Q2 2023 $1.38M -$45.3K -3.17% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.4M +$205K +17.1% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 $1.41M +$217K +18.1% Dec 31, 2022 10-Q 2023-08-11
Q3 2022 $1.41M +$321K +29.4% Sep 30, 2022 10-K 2024-02-15
Q2 2022 $1.43M +$600K +72.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.2M +$369K +44.6% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $1.2M +$104K +9.49% Dec 31, 2021 10-Q 2022-05-13
Q3 2021 $1.09M +$126K +13% Sep 30, 2021 10-K 2022-12-28
Q2 2021 $828K -$149K -15.3% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $828K -$126K -13.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.09M +$893K +446% Dec 31, 2020 10-Q 2022-05-13
Q3 2020 $968K +$621K +179% Sep 30, 2020 10-K 2021-12-17
Q2 2020 $978K Jun 30, 2020 10-Q 2020-07-23
Q1 2020 $954K Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $200K Dec 31, 2019 10-Q 2020-01-30
Q3 2019 $347K +$347K Sep 30, 2019 10-K 2020-12-11
Q3 2018 $0 Sep 30, 2018 10-K 2019-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.